Biotech company ready to sell its first product this summer  

Copenhagen based Poalis expects to be ready to sell its new method of vanillin production this summer

Danish biotech company Poalis expects to be ready to sell its new method for vanillin production this summer. Poalis uses microorganisms to produce flavourings, ingredients for the food industry and products for the pharmaceutical industry. Vanillin is produced in genetically modified yeast which reportedly gives stable production. Poalis' technology is patented and makes it possible to move biosynthetic pathways in plants to microorganisms.


Copenhagen based Poalis' main business areas are the development of biological production processes for speciality and fine chemicals as well as improved agricultural crops capable of resisting pests and fungus attacks. In 2003, Poalis received DKK 35 million (USD 5.6 million) in venture capital from Carlsberg, AgroVenture, Danisco Venture, Nordic Biotech and the Danish Fund for Industrial Growth. The news is reported by BiotechDenmark online.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×